• Home
  • Tags: World Anti-Doping Agency (WADA)

LawInSport Weekly News Recap - 8 October

LIS News Roundup

Welcome to LawInSport’s weekly News Roundup.  This recap highlights this week’s news pieces from across the world of sport. For further updates, please visit our news section.

We hope you find this useful. If you have any related questions or feedback, please don’t hesitate to contact us. 

UCI Statement concerning Marcin Polak

UCI Logo

The Union Cycliste Internationale (UCI) announces that the Polish rider Marcin Polak has been notified today of an Adverse Analytical Finding (AAF) for Erythropoietin (EPO)[1] in a sample collected during an out-of-competition doping control conducted on 2 August 2021.

Teamwork is the key for WADA’s Independent Observers at Tokyo 2020 Olympic Games


The Tokyo 2020 Olympic Games is full of teams. Hundreds of national teams, various squads of players for specific team events, individual athletes and their teams of coaches and entourage and even teams of organizers that are busy behind the scenes ensuring the Games run smoothly. And for the members of the World Anti-Doping Agency’s (WADA’s) Independent Observer (IO) team, it is every bit as important that they work together as a cohesive unit in order to be effective in monitoring the anti-doping system in place during the Games.



A small Working Group of governance experts was established by the WADA Executive Committee at its November 2020 meeting. The composition of this new Working Group on the Review of WADA Governance Reforms includes seven governance experts (two proposed by Governments, two by the Sport Movement, one independent Chair, and two expert athletes (nominated by WADA’s Athlete Committee). One of the athletes (Chelsey Gotell) was added to the Group in March 2021 following the decision of the Executive Committee in November 2020, that the Group could be expanded with an additional athlete, subject to an appropriate athlete expert being put forward by the WADA Athlete Committee. An essential part of the work of this Group will be to consult all stakeholders, including athletes and NADOs, using a wide-ranging consultation process in the same spirit as the one used for past World Anti-Doping Code reviews.

WADA strengthens global anti-doping system through re-build of its Anti-Doping Administration and Management System


In this latest edition of ‘Spotlight’, which keeps stakeholders up to date on the activities being carried out by the World Anti-Doping Agency (WADA) team and its partners, we look at WADA’s Anti-Doping Administration Management System (ADAMS), and how it is making athletes’ lives easier and the work of the anti-doping community more effective. Previous ‘Spotlight’ features are available on WADA’s website.

WADA revokes approval of Moscow Laboratory


Yesterday, by way of circulatory vote, the World Anti-Doping Agency’s (WADA’s) Executive Committee (ExCo) endorsed a WADA Disciplinary Committee recommendation to revoke the ‘approved’ status of the National Anti-Doping Laboratory (MSU) in Moscow (Moscow Laboratory) to carry out blood sample analysis exclusively for the purpose of the Athlete Biological Passport (ABP), due to non-compliances with the International Standard for Laboratories (ISL) and its Code of Ethics.

CAS Bulletin 2021/1

CAS Logo

In this Olympic year, the Court of Arbitration for Sport (CAS) has opened two temporary offices in Japan for the Tokyo 2020 Olympic Games (the Games) which have been postponed due to the coronavirus pandemic and have been held this year from 21 July to 8 August 2021.

WADA leadership engages Clean Sport partners during Tokyo 2020 Olympic Games


The World Anti-Doping Agency’s (WADA’s) President, Witold Bańka; Vice-President, Yang Yang; and Director General, Olivier Niggli, spent time in Tokyo last week and this week to attend the 2020 Olympic Games; and, have taken advantage of the opportunity to meet face-to-face with a significant number of WADA’s Clean Sport partners.

WADA partners with the Japan Anti-Doping Agency to promote the Play True message at the Tokyo Games


In the lead up to, and during the Tokyo 2020 Summer Olympic and Paralympic Games, the World Anti-Doping Agency (WADA) is partnering with the Japan Anti-Doping Agency (JADA) and other stakeholders to deliver a strong anti-doping program and promote the Play True message. As the host National Anti-Doping Organization (NADO) of the Tokyo Games, JADA plays an integral role in coordinating the anti-doping program in partnership with the International Olympic Committee, the International Testing Agency (ITA), the International Paralympic Committee the Tokyo Organizing Committee and WADA.

WADA statement on German broadcaster ARD documentary


The World Anti-Doping Agency (WADA) notes the contents of the 16 July 2021 documentary by German broadcaster, ARD, which makes a number of statements regarding the possibility of prohibited substances being passed through the skin of athletes via a process of sabotage.

WADA releases new education program for ‘Talented Athletes’


Today, the World Anti-Doping Agency (WADA) releases a new education program entitled ADEL for Talented Athletes’ which is available on the Agency’s Anti-Doping Education and Learning Platform (ADEL).

This new education program, specifically targeting ‘Talented Athletes’, is the sixth program that has been made available for athletes on ADEL. In line with the International Standard for Education (ISE), this program provides a solution for Anti-Doping Organizations (ADOs) wishing to educate athletes at the ‘talented level’ as defined and recommended within WADA’s Guidelines for Education.

U.S. Paralympic Track & Field Athlete David Prince Accepts Sanction for Anti-Doping Rule Violation


USADA announced today that David Prince, of Bradenton, Fla., an athlete in the sport of Paralympic track and field, has accepted a 12-month suspension for an anti-doping rule violation.

Prince, 37, tested positive for ostarine (enobosarm), as well as LGD-4033 (ligandrol) and its metabolite di-hydroxy-LGD-4033, as the result of samples collected out of competition on September 27, 2020, October 15, 2020, and November 11, 2020. Ostarine and LGD‐4033 are Non-Specified Substances in the class of Anabolic Agents and are prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic & Paralympic Committee National Anti-Doping Policy, and the International Paralympic Committee Anti-Doping Code, all of which have adopted the World Anti-Doping Code (the Code) and the World Anti-Doping Agency (WADA) Prohibited List.

WADA welcomes significant additional investment from the Government of Canada


The World Anti-Doping Agency (WADA) is grateful to the Government of Canada for its additional contribution of USD 748,390 (CAD 936,108) to WADA, which will be dedicated primarily to the Agency’s scientific research and intelligence and investigations (I&I) activities. In addition, around USD 55,000 of the contribution has been earmarked for education.


Legal Advisors

Copyright © LawInSport Limited 2010 - 2022. These pages contain general information only. Nothing in these pages constitutes legal advice. You should consult a suitably qualified lawyer on any specific legal problem or matter. The information provided here was accurate as of the day it was posted; however, the law may have changed since that date. This information is not intended to be, and should not be used as, a substitute for taking legal advice in any specific situation. LawInSport is not responsible for any actions taken or not taken on the basis of this information. Please refer to the full terms and conditions on our website.